Cargando…

MicroRNAs – novel biomarkers for malignant pleural effusions

Lung cancer is one of the most common causes of cancer death. Its poor prognosis can be attributed to the patients’ advanced or metastatic presentation at the time of diagnosis. To improve and accelerate the diagnosis, better therapeutic and diagnostic methods are constantly being sought. MicroRNAs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojczakowski, Wiktor, Kobylarek, Dominik, Lindner, Jacek, Limphaibool, Nattakarn, Kaczmarek, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883963/ https://www.ncbi.nlm.nih.gov/pubmed/31798327 http://dx.doi.org/10.5114/wo.2019.89241

Ejemplares similares

Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion
por: Yang, Yuan, et al.
Publicado: (2020)

Advances in the Potential Biomarkers of Epilepsy
por: Kobylarek, Dominik, et al.
Publicado: (2019)

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications
por: Limphaibool, Nattakarn, et al.
Publicado: (2019)

MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
por: Birnie, Kimberly A., et al.
Publicado: (2019)

Extracellular Vesicle MicroRNA in Malignant Pleural Effusion
por: Shojaee, Samira, et al.
Publicado: (2022)

Macrophages in malignant pleural effusions – alternatively activated tumor associated macrophages
por: Kaczmarek, Mariusz, et al.
Publicado: (2012)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion
por: HAN, HYE-SUK, et al.
Publicado: (2014)

MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
por: Ak, Guntulu, et al.
Publicado: (2015)

Bruns syndrome in a patient with intraventricular subependymoma: a case report
por: Iwanowski, Piotr, et al.
Publicado: (2023)

The role of microRNA‐93 regulating angiopoietin2 in the formation of malignant pleural effusion
por: Qian, Qian, et al.
Publicado: (2017)

GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
por: Liu, Yongxia, et al.
Publicado: (2021)

Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions
por: Budna, Joanna, et al.
Publicado: (2018)

Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021)

Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods
por: Darooei, Reza, et al.
Publicado: (2017)

MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions
por: Marqués, Marta, et al.
Publicado: (2023)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma
por: Walter, Robert Fred Henry, et al.
Publicado: (2016)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
por: Lo Russo, Giuseppe, et al.
Publicado: (2018)

Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future
por: Reid, Glen, et al.
Publicado: (2020)

Diagnostic value of microRNAs for malignant pleural mesothelioma: A mini‐review
por: Han, Yan‐Qiu, et al.
Publicado: (2020)

Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma
por: Dixit, Shivani, et al.
Publicado: (2022)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Malignant pleural effusions: Differentiating pelvic malignancies
por: Sharma, Mukesh, et al.
Publicado: (2015)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987)

Primary malignant myelomatous pleural effusion
por: Mangla, Ankit, et al.
Publicado: (2016)

Pleural procedures in the management of malignant effusions
por: Ferreiro, Lucía, et al.
Publicado: (2017)

Management of Septated Malignant Pleural Effusions
por: Banka, Radhika, et al.
Publicado: (2018)

Malignant Pleural Effusion: Diagnosis and Management
por: Ferreiro, Lucía, et al.
Publicado: (2020)

Surgical treatment in malignant pleural effusion
por: Karadayı, Şule, et al.
Publicado: (2021)

Malignant pleural effusion diagnosis and therapy
por: Yang, Liangliang, et al.
Publicado: (2023)

Clinical identification of malignant pleural effusions
por: Jia, Jianlong, et al.
Publicado: (2023)

Implantation of permanent pleural catheter for palliation of malignant pleural effusion
por: Meier, Michelle, et al.
Publicado: (2016)

Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
por: Báez-Saldaña, Renata, et al.
Publicado: (2017)

The diagnostic value of pleural fluid homocysteine in malignant pleural effusion
por: Santotoribio, Jose D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_krcto0q6j5vrkja63lbau9m4fg